- Home
- XENE vs ITGR Comparison
XENE vs ITGR Comparison
Compare XENE & ITGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XENE | ITGR |
|---|---|---|
| Founded | 1996 | 1970 |
| Country | | United States |
| Employees | N/A | 11000 |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 2.9B |
| IPO Year | 2014 | 2000 |
Fundamental Metrics
Financial Performance| Metric | XENE | ITGR |
|---|---|---|
| Price | $42.92 | $83.12 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 7 |
| Target Price | $54.09 | ★ $86.67 |
| AVG Volume (30 Days) | ★ 747.0K | 705.3K |
| Earning Date | 01-01-0001 | 05-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 24.91 |
| EPS | N/A | ★ 1.52 |
| Revenue | $311,000.00 | ★ $1,716,596,000.00 |
| Revenue This Year | N/A | $9.58 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $57.20 |
| Revenue Growth | N/A | ★ 7.51 |
| 52 Week Low | $26.74 | $62.00 |
| 52 Week High | $46.60 | $136.06 |
Technical Indicators
Market Signals| Indicator | XENE | ITGR |
|---|---|---|
| Relative Strength Index (RSI) | 56.04 | 45.88 |
| Support Level | $40.86 | $83.60 |
| Resistance Level | $43.67 | $87.36 |
| Average True Range (ATR) | 1.56 | 3.34 |
| MACD | 0.16 | -0.45 |
| Stochastic Oscillator | 80.56 | 2.54 |
Price Performance
Historical ComparisonAbout XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
About ITGR Integer Holdings Corporation
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The company also develops batteries used in nonmedical applications in the energy, military, and environmental markets. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns more than half of its revenue in the United States.